Ajanta Pharma Q3 Results Review - Asia, Africa Drive Earnings: Motilal Oswal
2 months ago•Bloomberg Quint
India Pharma - IPM Growth On Moderate Uptrend In September: Motilal Oswal
6 months ago•Bloomberg Quint
Pharma Key Molecule Check - Traction In Key Dr. Reddy’s, Lupin, Ajanta Pharma Products: Yes Securities
6 months ago•Bloomberg Quint
Ajanta Pharma Shares At All-Time High After August Sales Data
7 months ago•Bloomberg Quint
Stocks In Focus | Zomato, Sula, BHEL, RVNL, Ajanta Pharma & More | BQ Prime
7 months ago•Bloomberg Quint
Buy Ajanta Pharma; target of Rs 1580: ICICI Securities
8 months ago•Moneycontrol
Buy Ajanta Pharma; target of Rs 1800: Motilal Oswal
8 months ago•Moneycontrol